GLP1R and metabolic dysfunction-associated steatotic liver disease: Improved systemic inflammatory status could represent a significant cofactor in reducing the risk of NAFLD progression and HCC development, as well as a crucial determinant of the cardiovascular protection exerted by GLP-1 RAs [139].